Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/1996
12/24/1996US5587164 Vaccine for protection against porcine reproductive and respiratory disease
12/19/1996WO1996040961A1 Peptide-enhanced cationic lipid transfections
12/19/1996WO1996040955A1 Adenovirus vectors for gene therapy
12/19/1996WO1996040953A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996WO1996040948A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN
12/19/1996WO1996040933A1 Infectious dengue 2 virus pdk-53 as quadravalent vaccine
12/19/1996WO1996040932A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996WO1996040884A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996WO1996040880A1 Recombinant fowlpox viruses and uses thereof
12/19/1996WO1996040270A1 In vitro packaging of adeno-associated virus dna
12/19/1996WO1996040269A1 INCREASING rAAV TITER
12/19/1996WO1996040268A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996WO1996040241A1 Recombinant poxvirus-rabies compositions and combination compositions and uses
12/19/1996WO1996040240A1 Helper virus-free aav production
12/19/1996WO1996039843A1 Controlling hemipteran insect pests with bacillus thuringiensis
12/19/1996WO1996039841A1 Tumor- or cell-specific herpes simplex virus replication
12/19/1996WO1996039818A1 Treating red blood cell solutions with anti-viral agents
12/19/1996WO1996039816A1 Method of inactivation of viral and bacterial blood contaminants
12/19/1996WO1996036722A3 Embedded expression of heterologous proteins
12/19/1996DE19521705A1 Immunogenes Konstrukt, Verfahren zu dessen Herstellung und Verwendung als Vakzine An immunogenic construct, a process for its preparation and use as a vaccine
12/19/1996CA2787069A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2786782A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2224184A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996CA2223969A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996CA2223608A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2223591A1 Recombinant fowlpox viruses and uses thereof
12/19/1996CA2223416A1 Recombinant poxvirus-rabies compositions and combination compositions and uses
12/19/1996CA2222534A1 In vitro packaging of adeno-associated virus dna
12/19/1996CA2221733A1 Method of inactivation of viral and bacterial blood contaminants
12/19/1996CA2221240A1 Controlling hemipteran insect pests with bacillus thuringiensis
12/19/1996CA2199731A1 Treating red blood cell solutions with anti-viral agents
12/18/1996EP0748867A1 Marek's disease vaccine
12/18/1996EP0748631A2 Viral vaccines
12/18/1996EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
12/18/1996EP0748375A1 Selective virus culture
12/17/1996US5585262 Process for the production of a viable cell culture infected by a multiple sclerosis-associated virus
12/17/1996US5585096 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
12/17/1996US5585089 Humanized immunoglobulins
12/13/1996CA2178553A1 Marek's disease vaccine
12/12/1996WO1996039530A2 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof
12/12/1996WO1996039495A1 Aav directed targeted integration
12/12/1996WO1996039491A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996WO1996039179A1 Novel recombinant temperature sensitive mutants of influenza
12/12/1996WO1996039178A1 A replication-defective adenovirus human type 5 recombinant as a vaccine carrier
12/12/1996WO1996039177A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
12/12/1996WO1996039036A1 Composition and methods for creating syngeneic recombinant virus-producing cells
12/12/1996CA2423891A1 Novel recombinant temperature sensitive mutants of influenza
12/12/1996CA2223741A1 Aav directed targeted integration
12/12/1996CA2223419A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
12/12/1996CA2223282A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996CA2222880A1 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof
12/11/1996EP0746624A1 Vector for liver-specific gene therapy
12/10/1996US5583028 Recombinant vaccinia virus as DNA constructs encoding HSV glycoproteins
12/10/1996US5583023 Cloning of heterologous dna into endonuclease restriction sites and expression of dna inserted therein
12/10/1996US5583022 Defective recombinant retrovirus
12/10/1996US5582967 Human cell line LC5 and its use
12/05/1996WO1996038565A1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER
12/05/1996WO1996038556A2 Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer
12/05/1996WO1996038547A1 Insect diagnostic and control compositions with truncated jhe
12/05/1996WO1996038546A1 Herpes simplex type 1 protease mutants and vectors
12/05/1996WO1996038474A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
12/05/1996CA2222968A1 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
12/05/1996CA2222877A1 Herpes simplex type 1 protease mutants and vectors
12/05/1996CA2219861A1 .delta.p62, variants thereof, nucleic acid sequences and uses thereof
12/04/1996EP0745609A2 Vaccines for prophylaxis against HIV infections and/or for AIDS therapy and process for preparing them
12/04/1996EP0745133A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof
12/04/1996EP0745128A1 Hepatitis b virus mutants, reagents and methods for detection
12/04/1996EP0745121A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
12/03/1996US5580778 Isolation and diagnosis of coronaviruses as a factor in bovine shipping fever, and a cell line for culturing both those and other bovine coronaviruses
12/03/1996US5580772 Aids diagnosis, therapy
12/03/1996US5580739 Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
12/03/1996US5580725 Method of eliminating genetic routes for bacteriophage evolution and products produced thereby
12/03/1996US5580719 Isolating genomic rna from poliovirus, employing rna sequencing to determine nucleotide at position 2493
12/03/1996US5580718 Oligonucleotides
12/03/1996US5580717 Recombinant library screening methods
12/03/1996CA1338758C Process for the preparation of inducers of non-specific immunity
11/1996
11/28/1996WO1996037626A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
11/28/1996WO1996037625A1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof
11/28/1996WO1996037616A1 Alphavirus rna replicon systems
11/28/1996WO1996037608A1 Novel variants of apolipoprotein a-i
11/28/1996WO1996037220A1 cDNA CLONE FOR SOUTH AFRICAN ARBOVIRUS NO. 86
11/28/1996WO1996037218A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996WO1996029413A3 Dna encoding human papilloma virus type 18
11/28/1996CA2221818A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996CA2221708A1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof
11/28/1996CA2221155A1 Cdna clone for south african arbovirus no. 86
11/28/1996CA2218759A1 Novel variants of apolipoprotein a-i
11/27/1996CN1136826A Recombinant P53 adenovirus method and compositions
11/26/1996US5578715 Methods, kits, and probes for diagnosing HIV-2
11/26/1996US5578473 Recombinant negative strand RNA virus
11/21/1996WO1996036722A2 Embedded expression of heterologous proteins
11/21/1996WO1996036712A1 Recombinant baculovirus insecticides
11/21/1996WO1996036699A1 Non-pathogenic strains of hiv-1 and methods for detecting same
11/21/1996WO1996036364A1 Recombinant viral vector system
11/21/1996WO1996036356A1 Viral agent associated with mystery swine disease
11/21/1996WO1996036221A2 Insect control with multiple toxins
11/21/1996CA2221292A1 Recombinant viral vector system
11/20/1996EP0743366A1 Determination of Listeria using recombinant bacteriophages
11/20/1996EP0742834A1 Method of preparing a viral vector by homologous intermolecular recombination
11/20/1996EP0742833A1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies
1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 267